REMEGEN (09995) fell 10% to HK$12.62.
It hits an intra-day low of HK$12.6, hitting a historical low, and an intra-day high of HK$14.1. The total shares traded was 3.16 million, with a value of HK$41.58m. The active buy/sell ratio is 25:75, with net selling turnover of HK$20.68m. CHINA INV INFO accounts for greatest net responsive buying turnover of HK$4.73m, with volume weighted average price of HK$13.117. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling turnover of HK$1.96m, with volume weighted average price of HK$13.16. The stock has fallen a combined 13.2% over the past 3 consecutive trading days.
| Nominal | 12.620 | % Chg | -9.99% |
| High | 14.100 | Low | 12.600 |
| Shares Tr | 3.16m | Turnover | 41.58m |
| 10-D SMA | 14.088 | %H.V | 42.249 |
| 20-D SMA | 14.081 | VWAP | 13.154 |
| 50-D SMA | 18.005 | RSI14 | 28.825 |
| Stock (Code) | Price (HK$) | Change (%) |
|---|---|---|
| REMEGEN (09995) | 12.62 | -9.99 |
| HUTCHMED (00013) | 28.05 | -0.36 |
| GENSCRIPT BIO (01548) | 11.96 | -2.29 |
| INNOVENT BIO (01801) | 43.50 | +0.12 |
| WUXI XDC (02268) | 18.46 | +0.22 |
| WUXI BIO (02269) | 10.18 | -10.39 |
| TIGERMED (03347) | 28.50 | -5.47 |
| BEIGENE (06160) | 119.80 | +0.84 |
| ZAI LAB (09688) | 13.46 | +2.75 |
| AKESO (09926) | 47.15 | +2.28 |
【你點睇】工聯會調查指外勞輸入政策影響漸現，多個行業失業比例較高，促暫停輸入外勞，你是否認同？► 立即投票
